InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
CFODisclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the detailed record of transactions filed by Meier Richard A, Chief Financial Officer. Director active across 3 companies, notably Biomarin Pharmaceutical INC. Aggregated, 15 reports have been published. Activity tracked since 6 May 2021. The latest transaction was disclosed on 20 May 2025 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Meier Richard A
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations15 total
6,650 shares0Common StockSEC:0001048477-25-000076:0
6,600 shares@ US$63.1020.4% of flowCommon StockSEC:0001048477-24-000116:0
7,080 shares0Common StockSEC:0001048477-24-000108:0
3,000 shares0Common StockSEC:0001048477-24-000004:0
4,190 shares0Common StockSEC:0001209191-23-031975:0
8,500 shares@ US$67.8128.2% of flowCommon StockSEC:0001209191-23-030368:0
4,980 shares0Common StockSEC:0001567619-22-011798:0
57,230 shares@ US$28.2583.7% of flowCommon StockSEC:0001562180-22-004076:0
8,500 shares@ US$37.460.0027% mcap31.5% of flowCommon StockSEC:0001567619-22-009496:0
36,738 shares0Common StockSEC:0001562180-22-001159:0
6,346 shares@ US$26.93888.9% of flowCommon StockSEC:0001562180-21-007368:0
5,120 shares0Common StockSEC:0001567619-21-011316:0
15,000 shares@ US$26.4921.3% of flowCommon StockSEC:0001567619-21-009351:0
10,213 sharesCommon StockSEC:0000075252-16-000116:0
5,301 sharesCommon StockSEC:0000075252-16-000116:1
15 of 15 declarations
About Meier Richard A
Richard A. Meier is a Director and Executive Vice President at BIOMARIN PHARMACEUTICAL INC and Intersect ENT, Inc. He oversees the financial operations and strategy of the companies. Meier is responsible for managing financial resources and producing financial reports. His expertise in finance is essential for ensuring the growth and profitability of the companies.
